Zevra Therapeutics (ZVRA)

Zevra Therapeutics (ZVRA) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• ZVRA last traded at $10.10, -1.75% on the day.
• Zevra Therapeutics: P/E 10.5, revenue $136.07M over the last four quarters.
• Over the past year ZVRA returned -0.79%; year to date 12.72%.

Updated 2026-11-03 12:33 UTC